Close Menu

NEW YORK – Molecular oncology startup SEngine Precision Medicine announced today that it has raised $5.1 million in a Series A financing round.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.